New Results
Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic beta cells
View ORCID ProfileMichael A Kalwat, In Hyun Hwang, Jocelyn Macho, Magdalena G Grzemska, Jonathan Z Yang, Kathleen McGlynn, View ORCID ProfileJohn B MacMillan, View ORCID ProfileMelanie H Cobb
doi: https://doi.org/10.1101/337113
Michael A Kalwat
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
In Hyun Hwang
2Department of Pharmacy, Woosuk University, South Korea.
Jocelyn Macho
3Department of Chemistry & Biochemistry, UC Santa Cruz, Santa Cruz, CA
Magdalena G Grzemska
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Jonathan Z Yang
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Kathleen McGlynn
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
John B MacMillan
3Department of Chemistry & Biochemistry, UC Santa Cruz, Santa Cruz, CA
Melanie H Cobb
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Posted June 04, 2018.
Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic beta cells
Michael A Kalwat, In Hyun Hwang, Jocelyn Macho, Magdalena G Grzemska, Jonathan Z Yang, Kathleen McGlynn, John B MacMillan, Melanie H Cobb
bioRxiv 337113; doi: https://doi.org/10.1101/337113
Subject Area
Subject Areas
- Biochemistry (9096)
- Bioengineering (6737)
- Bioinformatics (23916)
- Biophysics (12066)
- Cancer Biology (9484)
- Cell Biology (13722)
- Clinical Trials (138)
- Developmental Biology (7614)
- Ecology (11645)
- Epidemiology (2066)
- Evolutionary Biology (15463)
- Genetics (10611)
- Genomics (14281)
- Immunology (9450)
- Microbiology (22753)
- Molecular Biology (9057)
- Neuroscience (48814)
- Paleontology (354)
- Pathology (1478)
- Pharmacology and Toxicology (2559)
- Physiology (3818)
- Plant Biology (8300)
- Synthetic Biology (2285)
- Systems Biology (6163)
- Zoology (1296)